Cart
sales@molnova.com
Home - Products - Others - Other Targets - NVS-ZP7-4

NVS-ZP7-4

CAS No. 2349367-89-9

NVS-ZP7-4( —— )

Catalog No. M24067 CAS No. 2349367-89-9

NVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 167 In Stock
5MG 150 In Stock
10MG 264 In Stock
25MG 534 In Stock
50MG 792 In Stock
100MG 1088 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    NVS-ZP7-4
  • Note
    Research use only, not for human use.
  • Brief Description
    NVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).
  • Description
    NVS-ZP7-4 is a inhibitor of Zinc transporter SLC39A7 (ZIP7).
  • In Vitro
    NVS-ZP7-4 increases ER zinc levels, suggesting functional modulation of ZIP7.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Zinc transporter SLC39A7 (ZIP7)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2349367-89-9
  • Formula Weight
    501.62
  • Molecular Formula
    C28H28FN5OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:120mg/mL (239.22 mM)
  • SMILES
    O=C(NC12CCN(C[C@H](Cc3ccccc3)Nc3nc(ccc(F)c4)c4s3)CC2)Nc2c1cccc2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nolin E, et al. Discovery of a ZIP7 inhibitor from a Notch pathway screen. Nat Chem Biol. 2019 Feb;15(2):179-188.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • SARS-CoV-2 Mpro-IN-9

    SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.

  • AKOS037652256

    AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.

  • Neuropeptide W-30 (h...

    Neuropeptide W-30 (human) is an important stress mediator in the central nervous system that modulates the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. Neuropeptide W-30 (human) is an endogenous ligand for the two structurally related orphan G-protein-coupled receptors (GPCRs) GPR7 and GPR8. Neuropeptide W-30 (human)activates and binds to both GPR7 and GPR8 at similar effective doses.

Sign In Join Free